Monday's ETF Movers: URA, IXC
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 16 2025
0mins
Should l Buy TPL?
Source: NASDAQ.COM
iShares Global Energy ETF Performance: The iShares Global Energy ETF is down approximately 2.1% in Monday afternoon trading, with Texas Pacific Land and APA shares declining by 3.1% and 2.8%, respectively.
Author's Opinion Disclaimer: The views expressed in the article are solely those of the author and do not necessarily represent Nasdaq, Inc.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TPL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TPL
Wall Street analysts forecast TPL stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 432.830
Low
1050
Averages
1050
High
1050
Current: 432.830
Low
1050
Averages
1050
High
1050
About TPL
Texas Pacific Land Corporation is the landowner in the State of Texas with approximately 882,000 surface acres of land, principally concentrated in the Permian Basin. Its segments include Land and Resource Management and Water Services and Operations. The Land and Resource Management segment focuses on managing Company’s oil and gas royalty interest and surface acres located in 19 different countries. The Land and Resource Management segment encompasses the business of managing its approximately 882,000 surface acres of land and its approximately 207,000 NRA of oil and gas royalty interests, principally concentrated in the Permian Basin. This segment consists of royalties from oil and gas, revenues from easements, commercial leases and renewables, and land and material sales. The Water Services and Operations segment encompasses the business of providing a full-service water offering to operators in the Permian Basin. Its services include water sourcing and produced water disposal.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Hudson Technologies Decline: Hudson Technologies has a net cash position of $34.17 million, representing 12.9% of its market cap, yet its sales have declined by an average of 7.6% annually over the past two years, indicating adverse market trends, while its earnings per share have fallen by 39.1% annually, suggesting deteriorating profitability.
- ResMed's Sustained Growth: ResMed boasts a net cash position of $817.3 million, or 2.6% of its market cap, with constant currency growth averaging 9.1% over the past two years, demonstrating its ability to expand globally, and its earnings per share have increased by 15.2% annually, indicating strong profitability.
- Texas Pacific Land's Asset Strength: Texas Pacific Land holds a net cash position of $127 million, accounting for 0.4% of its market cap, with annual revenue growth of 26.2% over the last decade, reflecting increased market share, and a gross margin of 95% highlights its superior unit economics.
- Investment Flexibility: All three companies possess strong cash flows, with Hudson Technologies facing challenges, while ResMed and Texas Pacific Land show promising growth potential, allowing them to leverage their cash flows for investments or share buybacks.
See More
- Job Market Expectations: According to FactSet consensus estimates, the U.S. is expected to add only 50,000 jobs in April, significantly lower than March's 178,000, indicating signs of economic slowdown that could impact investor confidence.
- Unemployment Rate Stability: The unemployment rate is anticipated to remain steady at 4.3%, suggesting that despite the decrease in job additions, the labor market remains relatively stable, potentially alleviating fears of an economic downturn.
- GDP Growth Situation: The U.S. GDP grew at a seasonally adjusted annualized rate of 2% in the first quarter, higher than the fourth quarter's 0.5% but below the 2.2% estimate, reflecting economic sluggishness that may influence future monetary policy decisions.
- Market Volatility: Despite a strong performance in April, with the S&P 500 and Nasdaq hitting record highs, investors should remain cautious of the upcoming
See More
- Record Market Performance: The S&P 500 closed at a record high on Thursday, rising 3% over three days and 7.6% since early April, indicating strong market confidence and a rebound in investor sentiment.
- Nasdaq's Strong Rebound: The Nasdaq Composite also reached a new high, up nearly 5% in three days and 11.2% in April, marking 11 consecutive days of gains, reflecting robust performance in tech stocks and optimistic market expectations for future growth.
- Big Tech Rotation: Microsoft's stock jumped 4.6% on Wednesday without a clear reason, but it has risen 11% in April, showing sustained investor interest in tech; Tesla also rose 12% in three days, indicating strong confidence in these companies.
- Decreased Volatility: The Cboe Volatility Index has dropped nearly 30% in April, linked to S&P 500 index options activity, suggesting a stabilization in market sentiment and reduced investor concerns about future market fluctuations.
See More
- Strait of Hormuz Situation: The U.S. blockade of Iranian ports in the Strait of Hormuz has led to heightened uncertainty in the oil market, as any attack could cause oil prices to soar, reflecting the precarious nature of current geopolitical tensions.
- Pipeline Developments: The construction of backup pipelines by Saudi Arabia and the UAE has halved the flow of shipborne oil through the Strait, with Saudi's capacity at 7 million barrels per day and UAE's at 1.5 million, reducing reliance on this critical chokepoint.
- Focus on Energy Security: Investors are advised to concentrate on companies enhancing energy security, such as GE Vernova, whose stock has surged 51%, indicating strong market confidence in its long-term growth potential amidst ongoing uncertainties.
- Optimism for Pipeline Companies: Kinder Morgan is highlighted as a top choice for oil and gas transport, boasting nearly 80,000 miles of pipeline; despite trading near all-time highs, demand for its core energy infrastructure remains robust, suggesting a favorable outlook for the sector.
See More
- Reserve Report Completion: Tethys Petroleum has completed a reserve report as of December 31, 2025, in collaboration with McDaniel and Associates Consultants, adhering to NI51-101 standards, indicating that total proved reserves remain broadly equivalent to last year, reflecting stability in resource management.
- Decline in Net Present Value: The net present value (NPV) for total proved and probable reserves in 2025 is approximately $474 million, down about 15% from $560 million in 2024, primarily due to falling Brent crude prices, highlighting the negative impact of market conditions on the company's financial health.
- Tax and Cost Pressures: Despite stable reserves, the high tax burden and costs significantly limit the benefits of accessing international markets, indicating that the current fiscal and regulatory framework poses substantial challenges for export activities, which could affect future investment decisions.
- Market Environment Challenges: Tethys faces a challenging market environment due to fluctuations in domestic and international oil prices, necessitating effective strategies to navigate external challenges and maintain competitiveness in Central Asia and the Caspian region.
See More
- Chip Stock Surge: Investors are favoring semiconductor companies, with Marvell's stock jumping nearly 7%, heading for a third consecutive positive session, indicating strong market confidence in the chip sector.
- Fair Isaac Decline: Fair Isaac's stock dropped over 12% after Barclays cut its 12-month price target from $2,400 to $1,950 while maintaining an overweight rating, reflecting market concerns about its future performance.
- Organon Acquisition Rumors: Organon's stock surged 24% amid reports that India's Sun Pharmaceutical Industries is considering a $12 billion acquisition, although Sun Pharma labeled the news as
See More











